EGFR-mediated interleukin enhancer-binding factor 3 contributes to formation and survival of cancer stem-like tumorspheres as a therapeutic target against EGFR-positive non-small cell lung cancer-Reference-Cited by-同舟云学术

EGFR-mediated interleukin enhancer-binding factor 3 contributes to formation and survival of cancer stem-like tumorspheres as a therapeutic target against EGFR-positive non-small cell lung cancer

Published:2018-02 Issue: Volume:116 Page:80-89
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Cheng Chun-Chia,Chou Kuei-Fang,Wu Cheng-Wen,Su Nai-Wen,Peng Cheng-Liang,Su Ying-Wen,Chang Jungshan,Ho Ai-Sheng,Lin Huan-Chau,Chen Caleb Gon-Shen,Yang Bi-Ling,Chang Yu-Cheng,Chiang Ya-Wen,Lim Ken-Hong,Chang Yi-Fang

Funder

Ministry of Science and Technology of Taiwan

Cheng Hsin General Hospital

Mackay Memorial Hospital

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference54 articles.

1. ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics;Arteaga;Cancer Cell,2014

2. The ERBB network: at last, cancer therapy meets systems biology;Yarden;Nat. Rev. Cancer,2012

3. YM155 as an inhibitor of cancer stemness simultaneously inhibits autophosphorylation of epidermal growth factor receptor and G9a-mediated stemness in lung cancer cells;Cheng;PLoS One,2017